Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.800
+0.030 (1.69%)
At close: Nov 22, 2024, 4:00 PM
1.840
+0.040 (2.22%)
After-hours: Nov 22, 2024, 7:58 PM EST
PACB Market Cap
PACB has a market cap or net worth of $492.95 million as of November 22, 2024. Its market cap has decreased by -72.89% in one year.
Market Cap
492.95M
Enterprise Value
942.56M
1-Year Change
-72.89%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $492.95M, a decrease of -40.17%. That is a compound annual growth rate of -3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 471.00M | -82.05% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 487.40M |
| Zevra Therapeutics | 487.32M |
| Esperion Therapeutics | 486.68M |
| Terns Pharmaceuticals | 485.00M |
| Opthea | 485.00M |
| Semler Scientific | 482.70M |
| Korro Bio | 474.22M |
| Celcuity | 472.66M |